Factors associated with residual symptom burden in patients with peritoneal dialysis: a cohort study
| Autor: | Quintal-Medina IA; Instituto Mexicano del Seguro Social, Hospital General de Zona No. 58, Servicio de Medicina Interna, Tlalnepantla de Baz, Estado de México, Ciudad de México. México., Rocha-González HI; Instituto Politécnico Nacional, Escuela Superior de Medicina, Ciudad de México. México., Noyola-García ME; Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades Dr. Bernardo Sepúlveda Gutiérrez, Servicio de Medicina Interna, Ciudad de México. México., Flores-Padilla MG; Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades Dr. Bernardo Sepúlveda Gutiérrez, Servicio de Medicina Interna, Ciudad de México. México. |
|---|---|
| Jazyk: | Spanish; Castilian |
| Zdroj: | Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2020 Apr 13; Vol. 58 (2), pp. 174-180. Date of Electronic Publication: 2020 Apr 13. |
| DOI: | 10.24875/RMIMSS.M20000015 |
| Abstrakt: | Background: Patients on peritoneal dialysis have residual symptoms that reduce their quality of life. Objective: To determine the associated factors of residual symptom burden in patients with continuous ambulatory peritoneal dialysis (CAPD). Material and Mehotds: An observational, longitudinal, prospective and analytical study was carried out in patients with chronic kidney disease, who were candidates for peritoneal dialysis. The Palliative Care Outcome Scale-Symptoms Renal (POS-S Renal) questionnaire was applied in predialysis and 3 months after CAPD. The residual symptom burden was determined three months after CAPD with a value ≥ 8 points of the POS-S Renal questionnaire. The clinical and biochemical variables coded in a dichotomous manner were compared with the residual symptom burden. Relative risk (RR) with 95% confidence intervals and logistic regression models were calculated. Results: Seventy patients were included. The mean of glomerular filtration rate (GFR) was 4.7 ± 2 ml/min/1.73 m 2 . The median of the POS-S Renal score in predialysis was 30 points, and 3 months after CAPD was 8 points. The slight symptom burden predialysis presented a RR of 0.18. Conclusions: The slight symptom burden predialysis is a protective factor independent for residual symptom burden three months after CAPD. (Copyright: © 2020 Revista Medica del Instituto Mexicano del Seguro Social.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|